These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 603279)

  • 21. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of massive arterial thrombosis caused by thrombocytopenia induced by heparin with local thrombolysis].
    Delagardelle C; Harf C; Dondelinger RF; Goffette P; Beissel J; Pesch C; Welter R
    Arch Mal Coeur Vaiss; 1990 Jan; 83(1):113-5. PubMed ID: 2106299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism.
    Stead RB; Schafer AI; Rosenberg RD; Handin RI; Josa M; Khuri SF
    Am J Med; 1984 Jul; 77(1):185-8. PubMed ID: 6741980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-coated catheters and heparin-induced thrombocytopenia.
    Laster J; Silver D
    J Vasc Surg; 1988 May; 7(5):667-72. PubMed ID: 3367431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
    Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
    Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arterial embolism and thrombocytopenia during heparin therapy].
    Hausberg M; Stöber K; Heidenreich S; Koc F; Stenzinger W; Spieker C; Rahn KH
    Schweiz Rundsch Med Prax; 1993 Jun; 82(22):668-71. PubMed ID: 8391714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
    Mattioli AV; Bonetti L; Sternieri S; Mattioli G
    Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.
    Shih AW; Sheppard JI; Warkentin TE
    Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heparin-induced thrombocytopenia. Perspectives in a therapeutic dilemma].
    Linde N; Tsakiris DA; Vogt A; Marbet GA
    Vasa; 1991; 20(2):157-63. PubMed ID: 1652180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of fraxiparin for the prevention and treatment of thromboembolism in patients with heparin-induced thrombocytopenia].
    Barkagan ZS
    Ter Arkh; 1993; 65(10):77-82. PubMed ID: 8296242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-associated thrombocytopenia treatment with low molecular weight heparin.
    Vitoux JF; Mathieu JF; Roncato M; Fiessinger JN; Aiach M
    Thromb Haemost; 1986 Feb; 55(1):37-9. PubMed ID: 3705006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heparin-induced type II thrombocytopenia as the etiology of severe recurrent pulmonary embolism].
    Nickels F; Müller T; Schulz C; Nabel C; Sigel A; Notheis W; Muders F; Reng M; Riegger GA; Pfeifer M
    Pneumologie; 2001 Jan; 55(1):44-50. PubMed ID: 11236357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies.
    Dyke CM; Aldea G; Koster A; Smedira N; Avery E; Aronson S; Spiess BD; Lincoff AM
    Ann Thorac Surg; 2007 Sep; 84(3):836-9. PubMed ID: 17720385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypercoagulation caused by heparin-associated type II thrombocytopenia].
    Bux-Gewehr I; Helmling E; Seyfert UT
    Z Kardiol; 1996 Sep; 85(9):656-60. PubMed ID: 8992808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
    Warkentin TE; Levine MN; Hirsh J; Horsewood P; Roberts RS; Gent M; Kelton JG
    N Engl J Med; 1995 May; 332(20):1330-5. PubMed ID: 7715641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-related thrombosis after myocardial infarction.
    Hawkins KA; Schwartz MJ
    Am Heart J; 1984 Dec; 108(6):1543-4. PubMed ID: 6507247
    [No Abstract]   [Full Text] [Related]  

  • 40. Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis.
    Wang TY; Honeycutt EF; Tapson VF; Moll S; Granger CB; Ohman EM
    Am J Med; 2012 Dec; 125(12):1214-21. PubMed ID: 22939359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.